UNSPSC 85651133: Supplement left hip muscle with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left hip muscle with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0KUP0KZ

UNSPSC 85651133 Supplement left hip muscle with nonautologous tissue substitute, open approach is a Commodity code that nominally describes a surgical procedure for hip muscle repair using synthetic tissue. However, recent state and local opportunities posted under this code show no alignment with orthopedic surgical implants or tissue products. Instead, the opportunities reflect a broad range of health administration, medical surveillance, and staffing services unrelated to the code's stated scope. The City of Phoenix Retirement Office is soliciting independent medical evaluation services for disability benefit determinations; the City of Long Beach is requesting a surgical benefit carve-out program manager for employees' voluntary elective procedures; the Washington State Department of Transportation is contracting for occupational medical surveillance across ferry system worksites; Harris County Juvenile Probation Department is seeking emergency and specialty healthcare for detained youth; Collier County is procuring pharmacy benefit management; and Santa Clara County Health System is building a temporary staffing pool for ancillary clinical roles. None of these solicitations involve prosthetic devices, tissue substitutes, or orthopedic implants for hip muscle repair.

The code shows activity across multiple state and local issuing bodies—state departments (Washington), county health systems (Santa Clara, Collier, Harris), cities (Phoenix, Long Beach), and a state transit authority (Washington State Ferries)—but the opportunities do not reflect procurement under the code's stated commodity. The geographic spread includes Arizona, California, Florida, Washington, and Texas. Because the recent solicitations are substantively unrelated to hip muscle supplementation with synthetic tissue, this code does not represent meaningful commercial opportunity for firms supplying orthopedic implants, tissue products, or surgical supplies. The mismatch between the code's nominal scope and the actual opportunities suggests either miscoding on the part of issuing bodies or that the code does not drive procurement activity in state and local markets.